69
Kelun-Biotech
6990.HK·HKEXChengdu CNFounded 20221,000 employees
Mid CapbiotechPublicOncology
Platform: ADC Platform
Market Cap
$3B
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (6990.HK)
Loading 6990.HK stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovainavolisib | 699-8762 | NDA/BLA | 2 | PI3Kα | UCFSGS | ||
| Daraglumide | 699-682 | Preclinical | 1 | PD-1 | SchizophreniaCeliac | ||
| Pemifutibatinib | 699-5911 | Phase 3 | 3 | BET | MDSHemophilia A |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Kelun-Biotech trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)